Breast Cancer

Data from Swedish Study of Tamoxifen Published

Published in Women's Health Weekly, May 22nd, 1995

Results of a Swedish survey assessing the risk of second cancers in women treated for breast cancer with tamoxifen were published in the May 3, 1995, issue of the Journal of the National Cancer Institute.

Preliminary results of this study were made public first at a scientific meeting in 1992 and again a year ago.

In this study, women taking 40 mg of tamoxifen daily for two to five years had a 40 percent decreased risk of cancer in the opposite breast, an almost six-fold increased risk of endometrial cancer, and no increased risk of liver cancer. In addition, the researchers noted a possible increased risk of stomach and colorectal cancers, although...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1995-05-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry